Additionally, using the cytogenetic definitions of the Microarray Innovations in Leukemia Study Group (MILE) study22, we analyzed the recent Naef et al.’s dataset23 which independently validated that IL1RL1 was elevated in AML regardless of the cytogenetic mutation (Supplementary Fig. 1B). Here, IL1RL1 is linked to acute myeloid leukemia.